2026 Michael Fountoulakis: Biology and Biochemistry Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	National Ranking	Publications	Citations
Biology and Biochemistry	73	6077	114	209	14645

Discipline name

D-Index

World Ranking

National Ranking

Publications

Citations

Biology and Biochemistry

6077

114

209

14645

Research.com Recognitions

2023 - Research.com Biology and Biochemistry in Switzerland Leader Award

Overview

Michael Fountoulakis is affiliated with Roche (Switzerland) in Switzerland, focusing primarily on environmental science. Their research encompasses several interconnected fields and topics that address water quality and sustainable environmental practices.

The main fields of study represented in their work include:

Environmental Science

Within these, their subfields of study involve:

Industrial and Manufacturing Engineering
Pollution
Renewable Energy, Sustainability and the Environment

Key topics in their research cover:

Water Quality Monitoring and Analysis
Algal biology and biofuel production
Wastewater Treatment and Nitrogen Removal
Pharmaceutical and Antibiotic Environmental Impacts

Michael Fountoulakis has contributed to several recent publications, including:

Use of the microalgae Chlorella Sorokiniana for municipal wastewater treatment: batch experiments (2022), published in Global NEST International Conference on Environmental Science & Technology
Combined use of anaerobic and aerobic moving bed biofilm reactors for micropollutants' removal from wastewater (2022), published in Global NEST International Conference on Environmental Science & Technology

The frequent publication venue for their work is the Global NEST International Conference on Environmental Science & Technology, with multiple papers presented there.

They have collaborated regularly with various researchers, including:

Athanasios S. Stasinakis
Georgia Gatidou
Danae Kotoula
Athanasia Iliopoulou
Eleni Irakleous-Palaiologou

Best Publications

Hydrolysis and amino acid composition analysis of proteins

Michael Fountoulakis;Hans-Werner Lahm

746
Citations
Comparison of protein precipitation methods for sample preparation prior to proteomic analysis.

Lei Jiang;Lin He;Lin He;Michael Fountoulakis

658
Citations
Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders.

Kurt Krapfenbauer;Ephrem Engidawork;Nigel Cairns;Michael Fountoulakis

388
Citations
Identification of Proteins by Matrix-Assisted Laser Desorption Ionization–Mass Spectrometry Following In-Gel Digestion in Low-Salt, Nonvolatile Buffer and Simplified Peptide Recovery

Michael Fountoulakis;Hanno Langen

311
Citations
Limitations of current proteomics technologies.

Spyros Garbis;Gert Lubec;Michael Fountoulakis;Michael Fountoulakis

284
Citations
Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis.

Laurence Ozmen;Danièle Roman;Michael Fountoulakis;Georges Schmid

278
Citations
Use of Genomics To Identify Bacterial Undecaprenyl Pyrophosphate Synthetase: Cloning, Expression, and Characterization of the Essential uppS Gene

Christian M. Apfel;Béla Takács;Michael Fountoulakis;Martin Stieger

265
Citations
Role of interferon-gamma in mediating the antitumor efficacy of interleukin-12

Michael J. Brunda;Leopoldo Luistro;Jill A. Hendrzak;Michael Fountoulakis

245
Citations
Proteomics in brain research: potentials and limitations

Gert Lubec;Kurt Krapfenbauer;Kurt Krapfenbauer;Michael Fountoulakis

240
Citations
Ligand-independent dimerization of the extracellular domain of the leptin receptor and determination of the stoichiometry of leptin binding

René Devos;Yves Guisez;José Van Der Heyden;David D.W. White

223
Citations
Two‐dimensional map of human brain proteins

Hanno Langen;Peter Berndt;Daniel Röder;Nigel Cairns

201
Citations
Two-dimensional map of the proteome of Haemophilus influenzae.

Hanno Langen;Béla Takács;Stefan Evers;Peter Berndt

197
Citations
Postmortem Changes in the Level of Brain Proteins

Michael Fountoulakis;Rosmarie Hardmeier;Harald Höger;Gert Lubec

196
Citations
The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease.

Seong Hwan Kim;Roman Vlkolinsky;Nigel Cairns;Michael Fountoulakis

193
Citations
Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer’s disease and Down Syndrome

S. H. Kim;M. Fountoulakis;N. Cairns;G. Lubec

188
Citations
Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease.

Byong Chul Yoo;Seong Hwan Kim;Nigel Cairns;Michael Fountoulakis

187
Citations
Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down syndrome and Alzheimer's disease brain is downregulated at the mRNA and dysregulated at the protein level.

G. Lubec;M. Nonaka;K. Krapfenbauer;M. Gratzer

186
Citations
Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome.

Byong Chul Yoo;Michael Fountoulakis;Nigel Cairns;Gert Lubec

182
Citations
Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis.

Dritan Turhani;Kurt Krapfenbauer;Dietmar Thurnher;Hanno Langen

178
Citations
Application of proteomics technologies in the investigation of the brain

Michael Fountoulakis

175
Citations